HI-PLUS: design of a cluster-randomized trial evaluating structured case management with telemonitoring to improve quality of life in heart failure.
Martha Schutzmeier, Viktoria Rücker, Jonas Widmann et al.
✦ AI-curated · Sources linked
In 30 seconds
The HI-PLUS trial is a cluster-randomized controlled trial designed to evaluate a structured case management intervention with telemonitoring aimed at improving quality of life in heart failure patients. Targeting 1350 patients across 56 clusters, the study compares the intervention to guideline-recommended care, with the primary endpoint being the change in heart failure-specific quality of life after 12 months, measured by the Kansas City Cardiomyopathy Questionnaire Overall Summary Score.
Key findings
- The trial targets 1350 heart failure patients across 56 clusters.
- The primary endpoint is change in quality of life after 12 months.
- The intervention includes telemonitoring and enhanced communication between care providers.
Why it matters
Improving quality of life in heart failure patients is crucial, as the condition significantly impacts daily functioning and well-being. Effective interventions could lead to better patient outcomes and reduced healthcare utilization.